Sisram Medical (SEHK:1696) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

1696 Overzicht aandelen

1696 fundamentele analyse
Sneeuwvlok Score
Waardering	5/6
Toekomstige groei	4/6
Prestaties in het verleden	2/6
Financiële gezondheid	5/6
Dividenden	3/6

Beloningen

Verhandeld tegen 86.7% onder onze schatting van de reële waarde

De winst zal naar verwachting met 22.66% per jaar groeien

Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Risicoanalyse

Winstmarges (6.6%) zijn lager dan vorig jaar (10.9%)

Onstabiel dividend track record

Sisram Medical Ltd Concurrenten

Gaush Meditech

SEHK:2407

HK$1.5b

Acotec Scientific Holdings

SEHK:6669

HK$2.5b

PW Medtech Group

SEHK:1358

HK$1.8b

Modern Dental Group

SEHK:3600

HK$3.9b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Sisram Medical
Historische aandelenkoersen
Huidige aandelenkoers	HK$4.04
52 Week Hoogtepunt	HK$6.48
52 Week Laag	HK$2.75
Bèta	1.37
11 maand verandering	25.86%
3 maanden verandering	14.77%
1 Jaar Verandering	-33.55%
33 jaar verandering	-63.47%
5 jaar verandering	-13.49%
Verandering sinds IPO	-50.25%

Recent nieuws en updates

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23

Recent updates

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24

Rendement voor aandeelhouders

	1696	HK Medical Equipment	HK Markt
7D	18.1%	20.3%	8.7%
1Y	-33.6%	-25.2%	19.7%

Rendement versus industrie: 1696 presteerde slechter dan de Hong Kong Medical Equipment -sector, die het afgelopen jaar een rendement van -25.2 % opleverde.

Rendement versus markt: 1696 presteerde slechter dan Hong Kong Market, dat het afgelopen jaar een rendement van 19.7 % opleverde.

Prijsvolatiliteit

Is 1696's price volatile compared to industry and market?
1696 volatility
1696 Average Weekly Movement	8.6%
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	7.1%
10% most volatile stocks in HK Market	14.7%
10% least volatile stocks in HK Market	3.6%

Stabiele aandelenkoers: De aandelenkoers van 1696 is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 9% ) van 1696 is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2013	1,026	Lior Dayan	www.sisram-medical.com

Sisram Medical Ltd houdt zich bezig met onderzoek, ontwerp, ontwikkeling, productie en verkoop van medische esthetische en tandheelkundige apparatuur, apparaten voor thuisgebruik, injectables en cosmeceuticals producten in Azië-Pacific, Europa, Noord-Amerika, Latijns-Amerika, het Midden-Oosten en Afrika. Het biedt producten en behandelingen voor verschillende wellness-activiteiten, waaronder ontharing, huidverjonging, acne en acnelittekens, contouren van lichaam en gezicht, pigmentatie en huidverbetering, vettransplantatie, huidvullers voor het gezicht, injectables voor huidweefselherstel, persoonlijke verzorging en esthetische tandheelkunde, transepidermale toediening, cellulitisbehandeling, striae, vasculaire en gepigmenteerde laesies, hydradermabrasie, blepharoplastie-niet-chirurgische ooglidlift, liposuctie, vrouwelijke gezondheid en seksuele rehabilitatie. Het bedrijf produceert, distribueert en verkoopt ook medische apparatuur.

Sisram Medical Ltd Samenvatting

Hoe verhouden de winst en inkomsten van Sisram Medical zich tot de beurswaarde?
1696 fundamentele statistieken
Marktkapitalisatie	HK$1.89b
Inkomsten(TTM)	HK$183.10m
Inkomsten(TTM)	HK$2.77b

10.3x

Koers/Winstverhouding

0.7x

P/S-verhouding

Is 1696 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
1696 resultatenrekening (TTM)
Inkomsten	US$356.40m
Kosten van inkomsten	US$136.86m
Brutowinst	US$219.54m
Overige uitgaven	US$195.99m
Inkomsten	US$23.55m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.05
Brutomarge	61.60%
Nettowinstmarge	6.61%
Schuld/Eigen Vermogen Verhouding	1.1%

Hoe presteerde 1696 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

3.9%

Huidig dividendrendement

40%

Uitbetalingsratio

1696 Overzicht aandelen

Beloningen

Risicoanalyse

Sisram Medical Ltd Concurrenten

SEHK:2407

HK$1.5b

SEHK:6669

HK$2.5b

SEHK:1358

HK$1.8b

SEHK:3600

HK$3.9b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Investor sentiment improves as stock rises 24%

Sisram Medical Ltd Receives Product Approval from the National Medical Products Administration

First half 2024 earnings released: EPS: US$0.023 (vs US$0.04 in 1H 2023)

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Dividend of HK$0.16 announced

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Recent updates

Investor sentiment improves as stock rises 24%

Sisram Medical Ltd Receives Product Approval from the National Medical Products Administration

First half 2024 earnings released: EPS: US$0.023 (vs US$0.04 in 1H 2023)

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Dividend of HK$0.16 announced

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Sisram Medical Ltd Declares A Final Dividend, Payable on or Around 9 September 2024

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Sisram Medical Ltd, Annual General Meeting, Jun 24, 2024

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023

Sisram Medical Ltd to Report Fiscal Year 2023 Results on Mar 20, 2024

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Investor sentiment deteriorates as stock falls 20%

Now 21% overvalued

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Sisram Medical Ltd Announces the Registration Application of Profhilo

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 19%

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

First half 2023 earnings released: EPS: US$0.04 (vs US$0.044 in 1H 2022)

Upcoming dividend of HK$0.17 per share at 2.3% yield

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Sisram Medical Ltd Announces Final Ordinary Dividend for the Year Ended December 31, 2022, Payable 07 September 2023

Sisram Medical Announces the Launch of Alma Veil for the U.S. Market

Sisram Medical Ltd. Receives the Clearance from the U.S. Food and Drug Administration

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 16%

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Sisram Medical Ltd, Annual General Meeting, Jun 28, 2023

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: US$0.086 (vs US$0.069 in FY 2021)

Investor sentiment deteriorates as stock falls 16%

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 19%

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Executive Director of the Company with Effect from January 1, 2023

Investor sentiment improved over the past week

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Investor sentiment improved over the past week

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Less than half of directors are independent

Investor sentiment improved over the past week

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Sisram Medical Ltd Provides Revenue Guidance for the Year 2022

First half 2022 earnings released: EPS: US$0.044 (vs US$0.037 in 1H 2021)